本文报告168例经 B 超检出,下腔静脉造影证实的 Budd-Chiari 综合征,其中65例行下腔静脉或肝静脉 PTA 或血管内支架置入。对 Budd-Chiari 综合征的临床表现、B 超声象、下腔静脉或肝静脉造影、CT 和其它 X 线征象进行了回顾性分析。168例中,下腔静脉隔膜型76例(45.2%),下腔静脉节段性狭窄或闭塞65例(38.7%),肝静脉开口闭塞10例(6.1%),下腔静脉+肝静脉闭塞17例(10%)。使用经皮下腔静脉或肝静脉球囊扩张和血管内支架置入是治疗 Budd-Chiari 综合征首选的、安全、有效的方法。其远期疗效(随访3～5年)显著。 This article reports 168 Budd-Chiari syndromes confirmed by B-mode ultrasonography and IVC angiography. Sixty-five patients underwent IVT or IVT with PTA or endovascular stenting. The clinical manifestations of Budd-Chiari syndrome, B ultrasound, inferior vena cava or hepatic venography, CT and other X-ray findings were retrospectively analyzed. Of the 168 patients, 76 (45.2%) had inferior vena cava septum, 65 (38.7%) had inferior vena cava stenosis or occlusion, 10 had open hepatic vein occlusion (6.1%), inferior vena cava and hepatic vein occlusion 17 cases (10%). The use of percutaneous inferior vena cava or hepatic vein balloon dilation and endovascular stenting is the preferred, safe and effective treatment for Budd-Chiari syndrome. The long-term efficacy (follow-up of 3 to 5 years) was significant.